While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...

Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.

With its Q4 2024 results on Wednesday, Novo Nordisk (NVO) announced a new Phase 3 trial to test its highly-anticipated weight loss therapy, CagriSema, after a December readout failed to meet investors ...

Find out all you need to know about Ozempic and other weight loss drugs, including the dangers and side effects ...

Novo's blockbuster diabetes drug Ozempic belongs to a class of drugs known as GLP-1 receptor agonists and has the same active ...

In November 2023 Colombia imposed a tax on highly processed foods and drinks. Authorities in Brazil, Canada and Peru have ...

Semaglutide, sold under the brand names of Ozempic, Rybelsus and Wegovy, is one of the most popular drugs on the market.

In the recent years, companies like Novo Nordisk and Eli Lilly have GLP-1 ... in addition to a reduced calorie diet and increased physical activity. Meanwhile, Tirzepatide, the active ingredient ...

Novo Nordisk is facing serious pressure from a powerful adversary. It still has plenty of leeway to penetrate its target market, for now. Investors should keep a close eye on this company.

A low purine diet typically centers around fruits, vegetables, and whole grains. It also minimizes the consumption of red meat, seafood, and alcohol. Healthcare professionals often recommend a low ...

Most people believe that they can eat whatever they want as long as they exercise diligently and burn the calories. This concept is far from accurate and its oversimplification does not align with the ...

Among business leaders in the meeting were Lars Fruergaard Jorgensen, CEO of Novo Nordisk, which generates more than half of its sales in the United States. Novo, which competes with U.S ...